Disclaimer for the use of GlucoBlink
Version 1.1 | October 2026
GlucoBlink is a secondary information display for data from an external CGM platform. It is intended to provide supplementary information, not as a standalone system for medical monitoring, diagnosis, treatment, or medical decisions. The product does not perform glucose measurements itself or determine insulin doses. The original CGM app or receiver remains authoritative for medical treatment decisions and the associated warnings.
Purpose and limitations of the display
GlucoBlink does not measure glucose itself. It displays data provided by an external sensor, app, or service. Depending on the selected source and settings, glucose values, trend arrows, changes compared to previous measurements, and the time since the last measurement may be visible, among other things.
The display does not replace a CGM system, official CGM app, receiver, blood glucose meter, insulin pump, or advice from a healthcare provider. The displayed information is not a diagnosis, treatment advice, or dosing advice.
No medical treatment decisions
Do not base insulin doses, corrections, changes to pump settings, medication, or other medical treatment choices on GlucoBlink. Always check values and warnings in the official app or receiver of the CGM system being used before making a treatment decision, and follow the instructions for use and your personal treatment plan.
A linked tracking app, cloud environment, or Nightscout installation is a supplementary data source and does not replace this check. Consult your treating healthcare provider if you have questions about your treatment.
Delayed or incorrect data
Data may be delayed, incomplete, outdated, or incorrect. This may be caused by sensor problems, loss of Wi-Fi or internet connection, power outages, server failures, incorrect settings, software errors, or changes by the data provider, among other things. A visible value does not automatically mean it is up to date.
Check the time since the last measurement, the correct person or data source, and the set unit, such as mmol/L or mg/dL. If data is missing, unexpected, or contradictory, use the original CGM system according to the associated instructions.
Symptoms and emergencies
Do not ignore physical symptoms because GlucoBlink shows a normal value or does not sound an alarm. If symptoms or expectations do not match the sensor value, or if you doubt the measurement, check with a blood glucose meter according to the instructions of your CGM system and your treatment plan. In a medical emergency, do not wait for the display or an alert; seek medical help immediately and call 112 in an emergency.
Supplementary alerts and range settings
GlucoBlink can compare received glucose values with the low and high limits set by the user. Depending on the configuration, the display may provide visual signals and sounds. These alerts are supplementary and do not form a standalone or guaranteed warning system for hypoglycemia, hyperglycemia, or other medical emergencies. Alerts may be delayed, fail to occur, or sound incorrectly. Their operation depends on the accuracy and timeliness of the data source, power supply, Wi-Fi, internet, software, and settings (including volume, snooze, and night settings). The absence of an alert does not mean that the glucose value is safe.
Do not use GlucoBlink as the sole warning system or as a replacement for supervision of children or other persons who need help. Keep the alarm functions of the original CGM system available and set according to the manufacturer's instructions and personal treatment plan. Check the supplementary alerts regularly and after changes to settings.
IOB and COB
If the linked source provides this data, GlucoBlink can display IOB and COB. IOB stands for estimated insulin on board; COB for estimated carbohydrates on board. These are calculations from the source, not directly measured values. They may depend on entered data, settings, and synchronization. Do not use this information to determine a dose or treatment via GlucoBlink.
Self-checks and external services
The user or responsible parent or caregiver ensures correct configuration, checks the data source, and keeps the original CGM system available. Protect login credentials and only give authorized persons access to the display and configuration. Data on the screen may be visible to bystanders.
The availability and operation of linked services are not fully under the control of the GlucoBlink provider. An available link does not imply approval or support by the provider of that service.
Privacy and security
GlucoBlink may process account or access information to connect with external services and display health-related data. Protect access to the device, the local configuration portal, and your network. Do not share the device without removing stored data and access information. Consult the separate privacy statement for information about which data is processed, where it is stored, any transfer to third parties, and applicable rights. This disclaimer does not replace a privacy statement or security measures.
Rights and responsibilities
This disclaimer describes the limitations of use and safety instructions for GlucoBlink. It does not exclude statutory consumer rights, statutory warranties, or liability that cannot be lawfully excluded. Reading or accepting this text does not mean waiving such rights.
Short warning for screen or configuration
GlucoBlink is exclusively a secondary information display. Do not use the displayed values or alerts for medical treatment decisions. Always check the official CGM app or receiver instead, and follow your treatment plan. Data and alerts may be delayed or fail to occur.
Regulations and product qualification
These usage warnings do not establish that GlucoBlink falls outside the European Medical Device Regulation (MDR) and are not a declaration of CE conformity. The legal qualification, applicable product safety rules, and obligations of the provider must be assessed separately based on the actual design, functions, and intended use.
Sources and explanation
This appendix contains the publicly listed sources. The safety principles have been incorporated in my own words; disclaimers and safety instructions from other displays and software have been used exclusively as background examples. The terms of other products have not been incorporated in full. Sources consulted on October 4, 2026.
Dexcom apps
Dexcom distinguishes primary CGM apps from supplementary apps. Values from Follow must be confirmed in the CGM app or receiver before treatment. Clarity is not intended for treatment decisions such as insulin dosing. For values that do not match symptoms, Dexcom refers to a blood glucose meter.
https://www.dexcom.com/en-us/apps
FreeStyle Libre and LibreLinkUp
Abbott states that LibreLinkUp may not be used for treatment or dosing and that the primary LibreLink app and/or healthcare provider is authoritative for this. This prohibition on using the tracking app must not be confused with the usage options of the original Libre system.
https://www.freestyle.abbott/ie-en/support/faq/question-answer.html?q=LibreLinkUpquestion-2